Scientia Professor Philip Mitchell (National speaker)

    Philip Mitchell AM, MB BS (Hons I), MD, FRANZCP, FRCPsych
  • Scientia Professor and Head of the School of Psychiatry at the University of New South Wales in Sydney, Australia
  • Member, Australian National Health and Medical Research Council (NHMRC) Research Committee
  • Councillor, CINP(Collegium Internationale Neuro-Psychopharmacologicum)
  • Consultant Psychiatrist, Prince of Wales Hospital, Sydney
  • Director, Bipolar Disorders Clinic, Black Dog Institute, Sydney
  • Member of the NHMRC Assigners Academy
  • Guest Professor, Shanghai Jiaotong University
  • Visiting Professor, Harbin Medical University, China
  • Board Member of the Black Dog Institute
  • Board Member of the Anika Foundation for Adolescent Depression and Suicide, Sydney

His research and clinical interests are in bipolar disorder and depression, with a particular focus on: predictors of the development of bipolar disorder in at-risk individuals; molecular genetics of bipolar disorder; pharmacological and psychological treatments for bipolar disorder and depression; clinical phenomenology of bipolar disorder and depression; and stimulatory therapies for depression (such as transcranial magnetic stimulation and direct current stimulation).

Professor Mitchell has published (in conjunction with colleagues) over 385 peer-reviewed papers or book chapters on these topics and is lead investigator on an Australian NHMRC-funded Program Grant on depression and bipolar disorder. He is an associate editor of ‘Therapeutic Advances in Chronic Disease’ and ‘Neuropsychiatry’, and also serves on the editorial boards of ‘Psychiatric Genetics’, ‘CNS Drugs’, ‘CNS Spectrums’, ‘Current Therapeutic Research’, ‘Therapeutic Advances in Psychopharmacology’ and ‘Medicine Today’.

In 2002 Prof. Mitchell was awarded the Senior Research Award of the Royal Australian and New Zealand College of Psychiatrists.  In 2004, he received the Founders Medal of the Australasian Society for Psychiatry Research.  In 2006, he received a Medical Media award from Research Australia for his media commentary on a wide range of mental health issues. In 2008, he received a Rotary International Vocational Excellence Award which recognizes outstanding contributions made by individuals or teams for significant advancement in their field in Australia.  In 2008, he was invited to give the endowed Samuel Novey Lecture in Psychological Medicine at Johns Hopkins University, Department of Psychiatry and Behavioral Sciences. In the 2010 Australia Day honours list Professor Mitchell was appointed as a Member of the Order of Australia for service to medical education, particularly in the field of psychiatry, as an academic, researcher and practitioner, through contributions to the understanding, treatment and prevention of mental illnesses

Dr Olivia Dean (National speaker)

Dr Dean is currently the Director of the Clinical Trials Division at the Innovation in Mental and Physical health And Clinical Treatments Strategic Research Centre (IMPACT SRC), based at the School of Medicine, Deakin University. She holds honorary appointments at The University of Melbourne, The Florey Institute of Neuroscience and Mental Health and Barwon Health. She is the Chair of the inaugural Australasian Bipolar and Depressive Disorders Early/Mid-Career Researcher Committee. Dr Dean has been responsible for the successful completion of a multitude of clinical trials, including both national and international sites. Over the past seven years, Dr Dean has developed a research program focusing on novel therapies for psychiatric disorders. The program includes multidisciplinary approaches, in addition to clinical trials, to understand the biological underpinnings of mental illness, specifically depression. The multifaceted research program allows identification of new targets for novel therapies and reverse-engineering of existing agents furthering the benefits of the clinical studies. The impact of this program is demonstrated by scientific metrics, such as publications and grant funding. Dr Dean is committed to disseminating findings through the media and to consumer groups so that there is further translation, but importantly so that education is provided for people to better understand mental illness. Ultimately, the program aims to identify targets that may not only provide therapeutic indicators for the best treatment options, but lead to the identification of factors resulting in disease prevention.

Professor Michael Berk (National speaker)

Professor John Tiller (National speaker)